文献速递中医内科中药与中成药合理使用

空间多组学揭示芍药苷经Oat、Aco1和Fh介导的代谢重编程及小管免疫串话改善IgA肾病

Spatially resolved multi-omics reveals that paeoniflorin ameliorates IgA nephropathy via Oat, Aco1 and Fh-mediated metabolic reprogramming and tubuloimmune crosstalk.
PubMed 文献 · Phytomedicine · 2026-05-01

该研究在大鼠 Thy-1 抗体诱导的 IgA 肾病模型中,用空间代谢组学与空间转录组学联合分析芍药苷的肾脏区域特异性作用。结果显示芍药苷在肾皮质经 Oat、Aco1、Fh 干扰三羧酸循环并上调精氨酸与脯氨酸代谢,减少损伤远端小管细胞比例及其共定位,体外实验验证其调控上述靶点并减轻炎症反应。

要点

  • 芍药苷在 IgAN 大鼠肾皮质诱导区域特异性代谢重编程。
  • 其作用与 Oat、Aco1、Fh 介导的三羧酸循环干扰相关。
  • 芍药苷可减少皮质损伤远端小管细胞比例及共定位。

核心结论

  • 芍药苷通过 Oat、Aco1 和 Fh 介导的代谢重编程及小管免疫串话改善 IgAN 大鼠肾损伤。
  • 空间多组学为 IgAN 分子发病机制提供空间视角并明确芍药苷治疗机制。

研究设计与样本

  • 研究采用 Wistar 大鼠经静脉注射 Thy-1 抗体建立 IgAN 模型。
  • 方法为空间代谢组学与空间转录组学整合分析,关键发现经体外功能实验验证。

主要发现

  • 芍药苷的治疗效应在空间上异质,与 IgAN 肾损伤的区域病理差异对应。
  • 空间多组学显示代谢活性与转录谱均存在显著区域异质性。
  • 在肾皮质,芍药苷经 Oat、Aco1、Fh 介导干扰三羧酸循环,并上调精氨酸与脯氨酸代谢。
  • 皮质中损伤远端小管细胞比例下降且共定位减弱。
  • 体外功能实验验证芍药苷调控 Oat、Aco1、Fh 并减轻炎症反应。

临床怎么用

  • 关注芍药苷及含芍药苷中药复方在 IgAN 中靶向 Oat、Aco1、Fh 与三羧酸循环的潜在价值。
  • 空间多组学可用于评估 IgAN 肾皮质区域特异性代谢与免疫串话改变。

局限性

  • 证据来自 Thy-1 抗体诱导的 IgAN 大鼠模型及体外实验,尚未在临床人群中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunoglobulin A nephropathy (IgAN), the most common primary glomerulonephritis globally, leads to a high lifetime risk of kidney failure. Shenhua Tablet (SHT), a Chinese herbal formula, demonstrates clinical efficacy in IgAN. Paeoniflorin (PF), its principal active constituent, shows anti-inflammatory and renoprotective effects in preclinical models; however, its precise molecular mechanisms in IgAN remain unclear. PURPOSE: This study aimed to elucidate the spatial molecular mechanisms underlying the therapeutic effect of PF in IgAN using an integrated multi-omics approach. STUDY DESIGN: A rat model of IgAN was established by intravenous injection of Thy-1 antibody in Wistar rats. This model was used to evaluate the renoprotective efficacy of PF, and the core pathways mediating its therapeutic effects were further investigated. METHODS: We applied an integrated spatial multi-omics approach, combining spatial metabolomics (SM) and spatial transcriptomics (ST), to investigate region-specific metabolic and transcriptional reprogramming in the kidney following PF treatment in IgAN model rats. Key findings were further validated through in vitro functional experiments. RESULTS: Our results uncovered spatially heterogeneous therapeutic effects of PF, corresponding to regional pathological variations in IgAN-induced renal injury. Spatial multi-omics analysis further revealed substantial regional heterogeneity in both metabolic activity and transcriptional profiles. In the renal cortex (CTX), PF administration induced region-specific metabolic reprogramming, primarily through Oat, Aco1, Fh mediated disruption of the TCA cycle, accompanied by upregulation of arginine and proline metabolism. Additionally, we observed a decreased proportion and diminished co-localization of injured distal tubule cells (DTCs) in the CTX. These multi-omics insights were further validated through in vitro functional assays, confirming PF's regulation of the Oat, Aco1, Fh and its role in attenuating inflammatory responses. CONCLUSION: These findings provide novel spatial perspectives on the molecular pathogenesis of IgAN and clarify the therapeutic mechanisms of PF, offering potential targets for developing more effective strategies to alleviate the global burden of this renal disease.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Wang M, Yin F, Li P, et al. Spatially resolved multi-omics reveals that paeoniflorin ameliorates IgA nephropathy via Oat, Aco1 and Fh-mediated metabolic reprogramming and tubuloimmune crosstalk. Phytomedicine. 2026. PMID: 42096999. doi:10.1016/j.phymed.2026.158263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。